Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Feb 2020
Historique:
received: 03 10 2019
revised: 16 12 2019
accepted: 20 12 2019
pubmed: 28 12 2019
medline: 21 11 2020
entrez: 28 12 2019
Statut: ppublish

Résumé

Fucoidan is a marine polymer extracted from diverse types of brown algae. This polysaccharide showed great potential towards treatment of different types of cancer. In this study, the activity of fucoidan extracted from Undaria Pinnatifida was investigated against pancreatic cancer (one of the most life-threatening cancers). Then, in an attempt to enhance the polymer's activity against cancer cells, conversion the polymer solution to nanoparticles was suggested to enhance its delivery through pancreatic cancer surrounding stroma. Novel fucoidan based nanoparticles were elaborated by polyelectrolyte interaction with the positively charged, active targeting ligand lactoferrin. The formulation was optimized through the interplay between different factors. Effect of fucoidan solution along with its blank nanoparticles was tested on the viability of pancreatic cancer cells and its migration and invasion abilities. Results confirmed the cytotoxic ability of fucoidan against pancreatic cancer. IC

Identifiants

pubmed: 31881303
pii: S0141-8130(19)37974-7
doi: 10.1016/j.ijbiomac.2019.12.177
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Polyelectrolytes 0
Polysaccharides 0
fucoidan 9072-19-9
Lactoferrin EC 3.4.21.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

390-401

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Samar M Etman (SM)

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt.

Ossama Y Abdallah (OY)

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt.

Yosra S R Elnaggar (YSR)

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt; Department of Pharmaceutics, Faculty of Pharmacy and Drug Manufacturing, Pharos University of Alexandria, Egypt. Electronic address: yosra_pharm@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH